跳至主要内容
临床试验/NCT02324556
NCT02324556终止不适用

A LAparoscopic and TransAnal Total Mesorectal Excision (TME for Rectal Cancer Trial

Sahlgrenska University Hospital, Sweden2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
6
试验地点
2
主要终点
Number of specimens with grade I specimen according to Quirke

研究概览

简要总结

All patients planned for an anterior resection due to rectal cancer with a total mesorectal excision are included. This is a feasibility study, thus no randomization will be performed.

Primary endpoint is clinical and pathologic examination of the specimen. Secondary end-points include clinical variables such as conversion rate, re-admission and/or re-operation due to any complication and health economy analyses.

详细描述

The design is comparative and prospective, we will compare specimens from patients operated at our institution during the last year with standard open or laparoscopic approach with patients operated with the new technique. Patients in the control arm will be patients operated prior to the commencement of the new technique or patients not eligible or possible to include in the study.

It is possible to obtain a macroscopically and microscopically adequate specimen after a combined approach with laparoscopic and transanal TME compared to open or laparoscopic conventional TME.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • presenting with a rectal cancer possible to operate with a total mesorectal excision and an anastomosis according to the local multidisciplinary conference
  • possible to operate with laparoscopic technique
  • possible to operate in regard to concomitant disease
  • giving informed consent to participate

排除标准

  • Participation in other trials in conflict with the protocol and end-points the LATA-trial

结局指标

主要结局

Number of specimens with grade I specimen according to Quirke

时间窗: 4 weeks postoperatively

Comparison with control group

次要结局

  • Conversion rate(day of surgery)
  • Re-admission(30 days)
  • Postoperative complications scored according to Clavien-Dindo within the first 12 months(12 months)

研究者

发起方
Sahlgrenska University Hospital, Sweden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eva Angenete

Senior Consultant Surgeon, Associate professor

Sahlgrenska University Hospital, Sweden

研究点 (2)

Loading locations...

相似试验